These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29305107)

  • 1. Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.
    Waters DJ; Chiang EC
    Free Radic Biol Med; 2018 Nov; 127():36-45. PubMed ID: 29305107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
    Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
    Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.
    Chiang EC; Shen S; Kengeri SS; Xu H; Combs GF; Morris JS; Bostwick DG; Waters DJ
    Dose Response; 2009 Dec; 8(3):285-300. PubMed ID: 20877485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.
    Waters DJ; Shen S; Kengeri SS; Chiang EC; Combs GF; Morris JS; Bostwick DG
    Nutrients; 2012 Nov; 4(11):1650-63. PubMed ID: 23201838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostatic housecleaning effect of selenium: evidence that noncytotoxic oxidant-induced damage sensitizes prostate cancer cells to organic selenium-triggered apoptosis.
    Chiang EC; Bostwick DG; Waters DJ
    Biofactors; 2013; 39(5):575-88. PubMed ID: 23625367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate.
    Waters DJ; Shen S; Cooley DM; Bostwick DG; Qian J; Combs GF; Glickman LT; Oteham C; Schlittler D; Morris JS
    J Natl Cancer Inst; 2003 Feb; 95(3):237-41. PubMed ID: 12569146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
    Moyad MA
    Urology; 2002 Apr; 59(4 Suppl 1):9-19. PubMed ID: 11937432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after].
    Koyama H; Mutakin ; Abdulah R; Yamazaki C; Kameo S
    Nihon Eiseigaku Zasshi; 2013; 68(1):1-10. PubMed ID: 23358371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues.
    Costello AJ
    Urology; 2001 Apr; 57(4 Suppl 1):182-4. PubMed ID: 11295622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
    Helzlsouer KJ; Huang HY; Alberg AJ; Hoffman S; Burke A; Norkus EP; Morris JS; Comstock GW
    J Natl Cancer Inst; 2000 Dec; 92(24):2018-23. PubMed ID: 11121464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium supplementation and prostate cancer mortality.
    Kenfield SA; Van Blarigan EL; DuPre N; Stampfer MJ; L Giovannucci E; Chan JM
    J Natl Cancer Inst; 2015 Jan; 107(1):360. PubMed ID: 25505227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
    Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC; Marshall JR
    Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
    Sabichi AL; Lee JJ; Taylor RJ; Thompson IM; Miles BJ; Tangen CM; Minasian LM; Pisters LL; Caton JR; Basler JW; Lerner SP; Menter DG; Marshall JR; Crawford ED; Lippman SM
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2178-84. PubMed ID: 16609032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
    Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
    Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
    BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.
    Waters DJ; Chiang EC; Cooley DM; Morris JS
    Mutat Res; 2004 Jul; 551(1-2):91-107. PubMed ID: 15225584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
    Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
    Trials; 2016 Aug; 17():400. PubMed ID: 27519183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.